Several reports indicate that transforming growth factor β1 (TGF-β1) participates in the regulation of cell cycle progression. In this work, we analyzed the in vitro effect of TGF-β1 on Leydig cell proliferation markers and the in vivo effect of this cytokine in Leydig cell hyperplasia/hypertrophy. The in vitro effect of TGF-β1 (1 ng/ml) plus progesterone (10-6 M) on purified Leydig cells from 3 week-old mice increased the immunocytochemically detected PCNA and stimulated the phosphorylation of Smad 1/5. Progesterone (10-6 M) in the presence or absence of TGF-β1 diminished the ratio Bax/Bcl-2. Morphometric testicular studies of mice treated with progesterone (s.c.) plus TGF-β1 (intratesticular), showed an increase in interstitial volume and a decrease in tubular volume. Furthermore, the cytoplasmic volume of Leydig cells showed an increment in this experimental group with a diminution in nuclear volume. Thus, it turned out that the administration of progesterone and TGF-β1 augmented the volume of Leydig cells. These results indicate a clear effect of TGF-β1 in the hypertrophy/hyperplasia of Leydig cells. © 2010 by the Society for Reproduction and Development.
CITATION STYLE
Gonzalez, C. R., Gonzalez, B., Rulli, S. B., dos Santos, M. L., Mattos Jardim Costa, G., França, L. R., … Gonzalez-Calvar, S. I. (2010). TGF-β1 system in leydig cells. Part II: TGF-β1 and progesterone, through Smad1/5, are involved in the hyperplasia/hypertrophy of leydig cells. Journal of Reproduction and Development, 56(4), 400–404. https://doi.org/10.1262/jrd.09-167N
Mendeley helps you to discover research relevant for your work.